Kenji Okami

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.

P Cairns, Kenji Okami, Sarel Halachmi et al. · PubMed · 1997 · 711 citations

Life Sciences, Genetics, Oncology +16

Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.

Hidenori Suzuki, Diha Freije, Deborah Nusskern et al. · PubMed · 1998 · 458 citations

Medicine, Genetics, Oncology +17

Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers

Paul Cairns, Ella Evron, Kenji Okami et al. · Oncogene · 1998 · 180 citations

Medicine, Genetics, Oncology +16

Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors.

Kenji Okami, Li Wu, Gregory J. Riggins et al. · PubMed · 1998 · 165 citations

Medicine, Genetics, Molecular Genetics +17